Vaccination of mice with MUC1 cDNA suppresses the development of lung metastases

Clin Exp Metastasis. 2002;19(8):689-96. doi: 10.1023/a:1021332932531.

Abstract

C57BL/6 mice were immunized intradermally with various doses of purified pCEP4 plasmid DNA containing full-length MUC1 cDNA (22 tandem repeats). Mice immunized with MUC1 DNA three times at weekly intervals had serum antibodies to a synthetic peptide corresponding to the tandem repeats of MUC1. The antibody titer correlated with the plasmid DNA dose. After the third immunization mice were injected intravenously with 5 x 10(5) 16-F10 melanoma cells that had been stably transfected with MUC1 cDNA (F10-MUC1-C8 clone cells). The number of lung metastatic nodules three weeks after inoculation of F10-MUC1-C8 cells was significantly lower in mice immunized with MUC1 plasmid DNA than in mice immunized with the vector DNA alone. Thus, the suppression of lung metastasis was antigen-specific. In vivo depletion of lymphocyte subpopulations by specific antibodies revealed that natural killer cells are the major effector cells responsible for the suppression of lung metastasis. CD4+ cells and CD8+ cells apparently played some roles too.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cancer Vaccines*
  • DNA, Complementary / administration & dosage*
  • Female
  • Genetic Therapy*
  • Humans
  • Lung Neoplasms / pathology*
  • Lung Neoplasms / prevention & control
  • Lung Neoplasms / secondary*
  • Mice
  • Mice, Inbred C57BL
  • Mucin-1 / administration & dosage
  • Mucin-1 / genetics*
  • Neoplasm Metastasis / prevention & control
  • Specific Pathogen-Free Organisms

Substances

  • Cancer Vaccines
  • DNA, Complementary
  • Mucin-1